Title:
超微粒化合物およびその製造
Document Type and Number:
Japanese Patent JP7444995
Kind Code:
B2
Abstract:
The present invention provides highly bioavailable and stable edible, inhalable, soluble and drinkable pharmaceutical grade ultrafine active pharmaceutical ingredients having 99% purity, and methods for their production.
Inventors:
Jackson, H Matthew
Oh, Jin-hee
Bryson, Julian
Oh, Jin-hee
Bryson, Julian
Application Number:
JP2022538055A
Publication Date:
March 06, 2024
Filing Date:
October 21, 2020
Export Citation:
Assignee:
Esolate Limited
International Classes:
A61K47/69; A23L2/52; A23L33/10; A23L33/105; A61K9/08; A61K9/107; A61K9/14; A61K9/16; A61K9/72; A61K31/05; A61K31/192; A61K31/352; A61K31/353; A61K31/4045; A61K45/00; A61P7/02; A61P21/02; A61P23/00; A61P25/08; A61P25/24; A61P29/00; A61P31/04; A61P31/12; C12G3/05
Domestic Patent References:
| JP2004511530A | ||||
| JP2006524670A | ||||
| JP2010522730A | ||||
| JP2010505605A |
Foreign References:
| US20050153931 | ||||
| US20190038995 |
Other References:
Chem. Eur. J.,2016年,22,pp.2972-2979
Pharmaceutical Research,1999年,16(12),pp.1864-1870
Pharmaceutical Research,1999年,16(12),pp.1864-1870
Attorney, Agent or Firm:
Kawaguchi International Patent Office